Evidence mapPaperPMID 40779178Full record

ArticleJournal of molecular histology2025

Protocol for the purification and culture of primary retinal ganglion cells and development of common pathological models.

Xiaoding Shui, Yan Wang, Yu Luo, Xiaoyu Liang, Tao Chen, Yanting Xia, Qiping Wei, Liang Liao

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular histology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaoding Shui *Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
Yan Wang *Beijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
Yu LuoBeijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
Xiaoyu LiangBeijing University of Chinese Medicine, Beijing, 100029, People's Republic of China.
Tao ChenBeijing Association of Chinese Medicine, Beijing, 100005, People's Republic of China.
Yanting XiaOphthalmology of Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, People's Republic of China.
Qiping WeiOphthalmology of Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, People's Republic of China.
Liang LiaoOphthalmology of Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, People's Republic of China. 58273677@qq.com.

Funding

"Jiebang Guashuai'' Program of Beijing University of Chinese Medicine 2024-JYB-JBZD-016National High Level Chinese Medicine Hospital Clinical Research Funding DFGZRB-2024GJRC014
6 · The paper itself

Abstract

To establish a standardized protocol for purifying and culturing primary RGC from postnatal KM mice and to optimize the establishment of three in vitro injury models that mimic hyperglycemia, oxidative stress, and H/R. Retinas from 15 postnatal KM mice (≤ 24 h old) were dissociated and purified via Thy1.2 monoclonal antibody-based immunopanning. RGC identity was confirmed by Brn3a (an RGC-specific marker) immunofluorescence, Tuj1 (a neuronal marker) immunostaining, flow cytometry, and trypan blue exclusion. Pathological models were constructed as follows: ①. Hyperglycemia: RGC were treated with 40-80 mM glucose for 24/48 h. ②. Oxidative stress: RGC were exposed to 80-320 μM H

Indexed as

Cell Culture TechniquesCell SeparationRetinal Ganglion CellsAnimalsCells, CulturedCell SurvivalDisease Models, AnimalGlucoseHydrogen PeroxideHyperglycemiaMiceOxidative StressGlucoseHydrogen PeroxideHyperglycemia modelHypoxia‒reoxygenation modelOxidative stress modelPrimary retinal ganglion cellsPurification culture

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.